As the global economy mends, the 2021 growth of Neuromodulation will have significant change from previous year. According to our (LP Information) latest study, the global Neuromodulation market size is USD million in 2022 from USD 5444.8 million in 2021, with a change of % between 2021 and 2022. The global Neuromodulation market size will reach USD 9002.8 million in 2028, growing at a CAGR of 7.4% over the analysis period.
The United States Neuromodulation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neuromodulation market, reaching US$ million by the year 2028. As for the Europe Neuromodulation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neuromodulation players cover Medtronic, Boston Scientific Corporation, Abbott, and LivaNova, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Internal Treatment
External Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Ischemia
Chronic Pain
Parkinson’s
Depression
Tremor
Epilepsy
Migraine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Synapse Biomedical, Inc.
Nevro Corporation
NeuroSigma
NeuroPace
Neuronetics
BioControl Medical